Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading?

Authors

Hengameh H Raissy
H William Kelly

Document Type

Article

Publication Date

3-1-2017

Abstract

International guidelines provide recommendations for a stepwise approach to the management of asthma in children 0-4 years old, 5-11 years old, and adolescents who are treated as adults. Therapy is aimed at two domains of control: current impairment and future risk. The long-term controller medications, inhaled corticosteroids (ICSs), ICSs in combination with long-acting β

Publisher

Adis International Ltd

Publication Title

Drug safety : an international journal of medical toxicology and drug experience

ISSN

1179-1942

Volume

40

Issue

3

First Page

201

Last Page

210

Recommended Citation

Raissy, Hengameh H and H William Kelly. "Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading?." Drug safety : an international journal of medical toxicology and drug experience , 3 (2017): 201-210. https://digitalrepository.unm.edu/peds_pubs/26